BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Thursday reported a loss of $26.2 million in its second quarter.

The Bala Cynwyd, Pennsylvania-based company said it had a loss of 41 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LRMR at https://www.zacks.com/ap/LRMR

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.